These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35006489)

  • 1. Survival analysis: A primer for the clinician scientists.
    Rai S; Mishra P; Ghoshal UC
    Indian J Gastroenterol; 2021 Oct; 40(5):541-549. PubMed ID: 35006489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biostatistics Series Module 9: Survival Analysis.
    Hazra A; Gogtay N
    Indian J Dermatol; 2017; 62(3):251-257. PubMed ID: 28584366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical primer: basics of survival analysis for the cardiothoracic surgeon.
    Thuijs DJFM; Hickey GL; Osnabrugge RLJ
    Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):1-4. PubMed ID: 29800119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival analysis and regression models.
    George B; Seals S; Aban I
    J Nucl Cardiol; 2014 Aug; 21(4):686-94. PubMed ID: 24810431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical application of cure mixture model for long-term censored survivor data from a withdrawal clinical trial of patients with major depressive disorder.
    Arano I; Sugimoto T; Hamasaki T; Ohno Y
    BMC Med Res Methodol; 2010 Apr; 10():33. PubMed ID: 20412598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cox regression model with randomly censored covariates.
    Atem FD; Matsouaka RA; Zimmern VE
    Biom J; 2019 Jul; 61(4):1020-1032. PubMed ID: 30908720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology.
    Horiguchi M; Hassett MJ; Uno H
    Clin Trials; 2020 Dec; 17(6):597-606. PubMed ID: 32933339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using cure models and multiple imputation to utilize recurrence as an auxiliary variable for overall survival.
    Conlon AS; Taylor JM; Sargent DJ; Yothers G
    Clin Trials; 2011 Oct; 8(5):581-90. PubMed ID: 21921063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulating survival data with predefined censoring rates for proportional hazards models.
    Wan F
    Stat Med; 2017 Feb; 36(5):838-854. PubMed ID: 27873333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression analysis of interval-censored survival data with covariates using log-linear models.
    Kim DK
    Biometrics; 1997 Dec; 53(4):1274-83. PubMed ID: 9423249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview on standard statistical methods for assessing exposure-outcome link in survival analysis (Part II): the Kaplan-Meier analysis and the Cox regression method.
    Abd ElHafeez S; Torino C; D'Arrigo G; Bolignano D; Provenzano F; Mattace-Raso F; Zoccali C; Tripepi G
    Aging Clin Exp Res; 2012 Jun; 24(3):203-6. PubMed ID: 23114547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival analysis: Part I - analysis of time-to-event.
    In J; Lee DK
    Korean J Anesthesiol; 2018 Jun; 71(3):182-191. PubMed ID: 29768911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaplan-Meier curves for survivor causal effects with time-to-event outcomes.
    Chiba Y
    Clin Trials; 2013 Aug; 10(4):515-21. PubMed ID: 23610455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression with a right-censored predictor using inverse probability weighting methods.
    Matsouaka RA; Atem FD
    Stat Med; 2020 Nov; 39(27):4001-4015. PubMed ID: 32779274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical methodology: IX. survival analysis.
    Young KD; Menegazzi JJ; Lewis RJ
    Acad Emerg Med; 1999 Mar; 6(3):244-9. PubMed ID: 10192678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cox model with interval-censored covariate in cohort studies.
    Ahn S; Lim J; Paik MC; Sacco RL; Elkind MS
    Biom J; 2018 Jul; 60(4):797-814. PubMed ID: 29775990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression models for the restricted residual mean life for right-censored and left-truncated data.
    Cortese G; Holmboe SA; Scheike TH
    Stat Med; 2017 May; 36(11):1803-1822. PubMed ID: 28106926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of censored data.
    Lucijanic M; Petrovecki M
    Biochem Med (Zagreb); 2012; 22(2):151-5. PubMed ID: 22838181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of colorectal adenoma recurrence with dependent censoring.
    Hsu CH; Long Q; Alberts DS
    BMC Med Res Methodol; 2009 Sep; 9():66. PubMed ID: 19788750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.